Overweight
📧 Sign up to get email alerts when something new happens for Overweight.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes [Phase 3]
An update on a Phase 3 master protocol evaluating Orforglipron (LY3502970) for obesity or overweight in participants with and without Type 2…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) [NA]
This clinical trial update indicates that the MEMORY study, investigating hormonal control of energy and macronutrient intake in obesity, is…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity [Phase 3]
A Phase 3 study of Orforglipron (LY3502970) in adults with obesity or overweight and at least one weight-related comorbidity is active but n…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity [Phase 1]
Pfizer is conducting a Phase 1 study to evaluate how PF-08653944 affects gastric emptying in healthy adults with overweight or obesity; the …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Lille Study for Childhood Health Promotion
Lille-based clinical trial update on a childhood health promotion study focusing on overweight and obesity; currently active but not recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program [NA]
A pilot study is being conducted to test a generative AI chatbot within a mobile weight loss program for individuals who are overweight or o…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide [Phase 3]
A Phase 3 clinical trial evaluating cagrilintide for weight loss in people with overweight/obesity and type 2 diabetes is currently active b…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity [Phase 2]
Phase 2 clinical trial evaluating different doses of UBT251 for overweight and obesity is currently recruiting, sponsored by Novo Nordisk A/…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight [Phase 2]
A Phase 2b clinical trial update for MET097 evaluating efficacy and safety in adults with obesity or overweight; the study is currently ACTI…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate [NA]
A clinical trial sponsored by NIDDK is investigating the effects of nicotinamide riboside on ketosis, fat oxidation, and metabolic rate in a…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4064912 in Healthy Participants and With Overweight or Obesity [Phase 1]
This is a Phase 1 clinical trial evaluating LY4064912 in healthy participants and in individuals with overweight or obesity; the study is cu…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight [Phase 2]
Eli Lilly is conducting a Phase 2 master protocol study (LY900038) with multiple intervention-specific appendices in adults with obesity or …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity [Phase 1]
A Phase 1 clinical trial evaluating Brenipatide (LY3537031) in healthy participants with obesity or overweight status is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants [Phase 1]
A Phase 1 clinical trial evaluating Zovaglutide (ZT002 Injection) in overweight and obese adults, including participants with impaired kidne…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome [NA]
Clinical trial update describing a study of functional snack foods containing safflower oil and soy in postmenopausal women with metabolic s…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Intervention Based on the Dietary Guidelines for the Brazilian Population for the Treatment of Overweight and Obesity [NA]
A ClinicalTrials.gov update on a Brazil-based trial evaluating a dietary guidelines-based intervention to treat overweight and obesity; the …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain [Phase 3]
Retatrutide (LY3437943) is being studied in a Phase 3 trial for obesity or overweight with chronic low back pain, and the study is currently…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes [Phase 3]
Phase 3 clinical trial investigating Eloralintide (LY3841136) in adults who are overweight or obese with Type 2 diabetes, currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight [Phase 3]
Phase 3 study of retatrutide for obesity and overweight; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial update assessing the effects of fasting duration and withholding tirzepatide on the amount of food and fluid in the stomach in…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity [Phase 1]
This Phase 1 trial update, sponsored by Amgen, is designed to assess whether Maridebart Cafraglutide affects the pharmacokinetics of oral co…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Human Models of Selective Insulin Resistance: Alpelisib, Part I [Phase 1]
Clinical trial update for a Phase 1 study evaluating alpelisib in models of selective insulin resistance, investigating its effects in insul…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Online Dietary Weight Loss Program for Arab Adults: A Randomized Controlled Trial [NA]
An ongoing randomized controlled trial evaluating an online dietary weight loss program for Arab adults with overweight or obesity.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Acute Sauna Session and Glucose Control [NA]
This ClinicalTrials.gov entry describes a University of Prince Edward Island study examining whether an acute sauna session can influence gl…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition [NA]
ClinicalTrials.gov update for the IMPACT study, examining immune and musculoskeletal adaptations to combined exercise training and nutrition…